New type 2 diabetes drug launched
The second of a new class of oral hypoglycaemic drugs for type 2 diabetes has been launched in the UK.
Recently Pulse revealed that GPs were increasingly turning from rosiglitazone to other prescribing options.
Vildagliptin, which is available alone and in combination with metformin, had a neutral effect on weight gain in clinical trials.
Dr Eugene Hughes, GP, Isle of Wight and chair of Primary Care Diabetes Europe, said the new drug could be ‘a potential solution to a very real problem.'